Glucos Viaflo Baxter (Glucose)

Glucos Viaflo Baxter is used in clinical settings where a rapid carbohydrate source is needed.

• Management of acute hypoglycemia in hospitalized patients.
• Supplementation during parenteral nutrition for patients unable to receive oral intake.
• Support of energy metabolism during surgery or critical illness.
• Dilution and administration of certain intravenous medications requiring a glucose carrier.
• Provision of glucose in diagnostic procedures such as glucose tolerance testing when intravenous delivery is required.
• Correction of electrolyte imbalances associated with low glucose levels.

Intravenous administration of glucose may be associated with a range of adverse effects, which are generally categorized as common or serious.

Common

• Transient hyperglycemia leading to elevated blood sugar levels.
• Local irritation or pain at the infusion site.
• Mild electrolyte shifts, particularly potassium changes.
• Nausea or vomiting if administered rapidly.
• Headache or dizziness.
• Transient increase in serum osmolality.

Serious

• Severe hyperglycemia with risk of osmotic diuresis.
• Hypersensitivity reactions, including rash or anaphylaxis.
• Fluid overload in patients with compromised cardiac function.
• Metabolic acidosis.
• Pulmonary edema.

When using Glucos Viaflo Baxter, clinicians should observe several precautions to minimize risks and ensure appropriate patient monitoring.

• Verify blood glucose levels before and after infusion to avoid extreme hyper- or hypoglycemia.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Use aseptic technique to reduce risk of catheter-related infections.
• Monitor electrolyte concentrations, especially potassium and sodium, during prolonged administration.
• Consider contraindications such as known glucose intolerance or severe hyperglycemia.
• Store the solution according to manufacturer guidelines to maintain sterility.
• Assess for signs of allergic reaction during the first minutes of infusion.
• Avoid use in patients receiving high-dose dextrose-containing medications without adjusting total carbohydrate load.

Glucose solutions can interact with other medications or clinical conditions, requiring careful consideration of concurrent therapies.

Avoid

• Co-administration with insulin without dose adjustment, which may cause severe hypoglycemia.
• Simultaneous infusion of high-concentration potassium solutions, increasing risk of hyperkalemia.
• Use with medications that contain dextrose in excess, leading to cumulative glucose overload.
• Mixing with calcium‑containing solutions, which may precipitate.

Use with caution

• Concurrent use of diuretics that affect fluid balance; monitor for volume status.
• Patients receiving corticosteroids, which can raise blood glucose; monitor levels closely.
• Administration alongside contrast agents for imaging; observe for transient hyperglycemia.
• Patients on beta‑blockers, as they may mask hypoglycemia symptoms.
• Patients with severe liver disease; monitor glucose metabolism closely.